ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/·4

Jan 4, 5:23 PM ET

ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ 4

4 · ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ · Filed Jan 4, 2008

Insider Transaction Report

Form 4
Period: 2008-01-02
Nolan Michael Francis
Chief Operating Officer
Transactions
  • Award

    Stock Options

    2008-01-02+7,50017,500 total
    Exercise: $7.15Exp: 2014-01-02Common Stock (7,500 underlying)
Footnotes (2)
  • [F1]The option holder may exercise purchase rights for 1,500 shares on or after 1/2/2009, and 1,500 each on or after anniversary date each year until 7,500 shares are exercised.
  • [F2]The consideration for the options is the option holder's future service to the company.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4